anonymous
Guest
anonymous
Guest
Short term incentives for pharma are only receiving 37.5% and merit increases range from 3.65-1.5%.
I love the mission of CVR but it is becoming harder and harder to understand where Bayer is going to be ABLE to take this and other products. 35 billion euros in dept changes everything. DSO will never overcome that challenge. In the Capital Markets day meeting, it was said most of the cost would be payroll. Payroll is now 11 billion. 500 million had to be cut this year- it was about 56 min mark when the recording becomes available.
I love the mission of CVR but it is becoming harder and harder to understand where Bayer is going to be ABLE to take this and other products. 35 billion euros in dept changes everything. DSO will never overcome that challenge. In the Capital Markets day meeting, it was said most of the cost would be payroll. Payroll is now 11 billion. 500 million had to be cut this year- it was about 56 min mark when the recording becomes available.